The latency-associated ul138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF) signaling by upregulating tnf receptor 1 cell surface expression

Journal of Virology

Volumn 85, Issue 21, 2011, Pages 11409-11421

  Montag, Christina ^a   Wagner, Jutta Annabella ^a   Gruska, Iris ^a   Vetter, Barbara ^a   Wiebusch, Lüder ^a   Hagemeier, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN UL138; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS ISOLATION; VIRUS LATENCY; VIRUS STRAIN;

CELLS, CULTURED; CYTOMEGALOVIRUS; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 80055115106     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05028-11     Document Type: Article

References (54)

1. Atalay, R., et al. 2002. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fc receptor homologs. J. Virol. 76:8596-8608.
2. Baillie, J., D. A. Sahlender, and J. H. Sinclair. 2003. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor. J. Virol. 77:7007-7016.
3. Bartee, E., M. R. Mohamed, and G. McFadden. 2008. Tumor necrosis factor and interferon: cytokines in harmony. Curr. Opin. Microbiol. 11:378-383.
4. Bego, M., J. Maciejewski, S. Khaiboullina, G. Pari, and S. St Jeor. 2005. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79:11022-11034.
5. Benedict, C. A., et al. 2004. Neutrality of the canonical NF-_B-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J. Virol. 78:741-750.
6. Bradley, A. J., et al. 2009. High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169. J. Gen. Virol. 90:2375-2380.
7. Caposio, P., A. Luganini, G. Hahn, S. Landolfo, and G. Gribaudo. 2007. Activation of the virus-induced IKK/NF-_B signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell. Microbiol. 9:2040-2054.
8. Cha, T. A., et al. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
9. Chee, M. S., et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
10. Chuang, H. C., et al. 2007. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. Am. J. Pathol. 170:1607-1617.
11. Dargan, D. J., et al. 2010. Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J. Gen. Virol. 91:1535-1546.
12. Dolan, A., et al. 2004. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85:1301-1312.
13. Dunn, W., et al. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
14. Fessler, S. P., Y. R. Chin, and M. S. Horwitz. 2004. Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. J. Virol. 78:13113-13121.
15. Filippova, M., H. Song, J. L. Connolly, T. S. Dermody, and P. J. Duerksen-Hughes. 2002. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem. 277:21730-21739.
16. Frascaroli, G., et al. 2009. Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J. Immunol. 182:477-488.
17. Goodrum, F., M. Reeves, J. Sinclair, K. High, and T. Shenk. 2007. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937-945.
18. Grainger, L., et al. 2010. Stress-inducible alternative translation initiation of human cytomegalovirus latency protein pUL138. J. Virol. 84:9472-9486.
19. Greaves, R. F., and E. S. Mocarski. 1998. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72:366-379.
20. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 95:3937-3942.
21. Hahn, G., D. Rose, M. Wagner, S. Rhiel, and M. A. McVoy. 2003. Cloning of the genomes of human cytomegalovirus strains Toledo, Towne-varRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique. Virology 307:164-177
22. Herbein, G., and W. A. O'Brien. 2000. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 223: 241-257.
23. Jarvis, M. A., et al. 2006. Human cytomegalovirus attenuates interleukin-1 and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-_B activation. J. Virol. 80:5588-5598.
24. Jenkins, C., A. Abendroth, and B. Slobedman. 2004. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol. 78:1440-1447.
25. Jones, S. J., et al. 1999. TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J. Immunol. 162:1042-1048.
26. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. U. S. A. 91:11879-11883.
27. Landolfo, S., M. Gariglio, G. Gribaudo, and D. Lembo. 2003. The human cytomegalovirus. Pharmacol. Ther. 98:269-297.
28. Liang, L., and B. Roizman. 2006. Herpes simplex virus 1 precludes replenishment of the short-lived receptor of tumor necrosis factor alpha by virion host shutoff-dependent degradation of its mRNA. J. Virol. 80:7756-7759.
29. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
30. Montag, C., J. Wagner, I. Gruska, and C. Hagemeier. 2006. Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1-mediated NF-_B signaling. J. Virol. 80:11686-11698.
31. Murphy, E., et al. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 100:14976-14981.
32. Neznanov, N., et al. 2001. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J. Virol. 75:10409-10420.
33. Petrucelli, A., M. Rak, L. Grainger, and F. Goodrum. 2009. Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. J. Virol. 83:5615-5629.
34. Poole, E., et al. 2009. Identification of TRIM23 as a cofactor involved in the regulation of NF-_B by human cytomegalovirus. J. Virol. 83:3581-3590.
35. Poole, E., C. A. King, J. H. Sinclair, and A. Alcami. 2006. The UL144 gene product of human cytomegalovirus activates NF_B via a TRAF6-dependent mechanism. EMBO J. 25:4390-4399.
36. Prichard, M. N., M. E. Penfold, G. M. Duke, R. R. Spaete, and G. W. Kemble. 2001. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11:191-200.
37. Reeves, M. B., P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J. Gen. Virol. 86:2949-2954.
38. Revello, M. G., and G. Gerna. 2010. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications. Rev. Med. Virol. 20:136-155.
39. Saederup, N., and E. S. Mocarski, Jr. 2002. Fatal attraction: cytomegalovirus-encoded chemokine homologs. Curr. Top. Microbiol. Immunol. 269: 235-256.
40. Sedger, L. M., et al. 2006. Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death. J. Virol. 80:9300-9309.
41. Sinclair, J., and P. Sissons. 2006. Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87:1763-1779.
42. Sinzger, C., M. Digel, and G. Jahn. 2008. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 325:63-83.
43. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Interferongamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100:3154-3163.
44. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
45. Stanton, R. J., et al. 2010. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J. Clin. Invest. 120:3191-3208.
46. Stein, J., H. D. Volk, C. Liebenthal, D. H. Kruger, and S. Prosch. 1993. Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol. 74:2333-2338.
47. Straschewski, S., et al. 2011. Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and block of migration. J. Virol. 85:5150-5158.
48. Taylor-Wiedeman, J., G. P. Hayhurst, J. G. Sissons, and J. H. Sinclair. 1993. Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J. Gen. Virol. 74:265-268.
49. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:2059-2064.
50. Wang, W., et al. 2005. Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice. J. Virol. 79:2115-2123.
51. Wilkinson, G. W., et al. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41:206-212.
52. Yang, S., et al. 2006. Using DNA microarray to study human cytomegalovirus gene expression. J. Virol. Methods 131:202-208.
53. Zydek, M., C. Hagemeier, and L. Wiebusch. 2010. Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog. 6:31001096.
54. Zydek, M., et al. General blockade of HCMV immediate early mRNA expression in SIG2 by a nuclear, Daxx- and PML-independent mechanism. J. Gen. Virol., in press.